ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MGP Medica Group Plc

211.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medica Group Plc LSE:MGP London Ordinary Share GB00BYV24996 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 211.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Medica Group PLC Block Listing Application (1720E)

05/07/2021 10:49am

UK Regulatory


Medica (LSE:MGP)
Historical Stock Chart


From Apr 2021 to Apr 2024

Click Here for more Medica Charts.

TIDMMGP

RNS Number : 1720E

Medica Group PLC

05 July 2021

Medica Group plc

Block Listing Application

Medica Group plc (the "Company") announces that application has been made to the London Stock Exchange and FCA for a total of 38,076 ordinary shares of 0.2 pence each in the Company to be admitted to the Official List of the FCA and admitted to trading on the London Stock Exchange.

These shares will be allotted in accordance with the Company's 2018 Sharesave Scheme.

Admission is expected to become effective on 6 July 2021.

The shares will be issued fully paid and will rank pari passu in all respects with the existing issued ordinary shares of the Company.

For further information, please contact:

 
 Medica Group Plc: 
  Dr. Stuart Quin, Chief Executive 
  Officer 
  Richard Jones, Chief Financial 
  Officer                             +44 (0)33 33 111 222 
 Investec Bank plc (Joint Broker) 
  Sara Hale 
  Daniel Adams 
  Virginia Bull                       +44 (0)20 7597 5970 
 Liberum (Joint Broker) 
  Bidhi Bhoma 
  Richard Lindley 
  Euan Brown                          +44 (0)20 3100 2000 
 FTI Consulting 
  Victoria Foster Mitchell 
  Sam Purewal                         +44 (0)20 3727 1000 
 

About Medica Group PLC

Medica is the market leader in the UK and Ireland for the provision of teleradiology services, providing outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerised tomography), ultrasound and plain film (x-ray) images. Medica also offers diabetic retinopathy screening in Ireland.

Medica contracts with the largest pool of consultant radiologists in the UK and Ireland, performing remote access teleradiology across its customer base of more than 100 NHS Trusts in the UK, the Irish HSE, private hospital and insurance groups, as well as diagnostic imaging companies. This enables the Company to offer a fast, responsive service. In addition, Medica operates in Australia and New Zealand through MedX, a 50:50 Joint Venture with Integral Diagnostics Limited Pty.

The Company currently offers two primary services to hospital radiology departments:

   --    NightHawk - urgent reporting service 

-- Elective - includes routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

These services are underpinned by Medica's bespoke, secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and consultant radiologists who contract with the Company. Direct RIS access ensures that where the wider patient medical history is available, it can be reviewed by the consultant as part of every report.

Through its subsidiary, RadMD, in the United States, Medica also provides pharmaceutical and biotech clients and contract research organisations (CROs) with high quality, complex imaging services for international clinical trials. RadMD has gained vast experience in the space, having contributed to over 500 international clinical trials, in all phases of clinical research from proof of concept to phase III and with expertise in oncology, as well as a wider range of therapeutic areas including medical devices, neurology and cardiovascular.

For more information please visit: www.medicagroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSUVSKRAVUBRRR

(END) Dow Jones Newswires

July 05, 2021 05:49 ET (09:49 GMT)

1 Year Medica Chart

1 Year Medica Chart

1 Month Medica Chart

1 Month Medica Chart

Your Recent History

Delayed Upgrade Clock